Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B-1

被引:50
作者
Dycaico, MJ
Stuart, GR
Tobal, GM
deBoer, JG
Glickman, BW
Provost, GS
机构
[1] STRATAGENE, LA JOLLA, CA 92037 USA
[2] UNIV VICTORIA, CTR ENVIRONM HLTH, VICTORIA, BC V8W 3NS, CANADA
关键词
D O I
10.1093/carcin/17.11.2347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vivo mutations were studied in lambda/lacI (Big Blue(R)) transgenic C57BL/6 mice and F344 rats following exposure to either AFB(1) (aflatoxin B-1) or DMSO vehicle. Fourteen days after exposure, livers were removed for DNA extraction and subsequent mutational analysis of the lad gene, Mice injected with a single i.p. dose of AFB(1) at 2.5 mg/kg did not show a significant increase in liver mutant frequency relative to vehicle-treated controls, DNA sequence analysis of lad mutations collected from the AFB(1)-treated mice showed a pattern of mutation similar to that of the previously observed spontaneous mouse liver mutational spectrum. In contrast, rats subjected to one-tenth the mouse AFB(1) dosage responded with an approximate 20-fold induction in liver mutant frequency over background, Sequencing of lad mutations also revealed spectral differences between vehicle- and AFB(1)-treated rats. A large increase in G:C-->T:A transversions was observed among lad mutations isolated from the AFB(1)-treated rats, This work is among the first multi-species in vivo mutagenicity studies using transgenic rodents harboring the same shuttle vector. Such multi-species in vivo assays may prove to be valuable in the areas of mechanistic analysis and risk assessment.
引用
收藏
页码:2347 / 2356
页数:10
相关论文
共 51 条
[41]  
PROVOST GS, 1993, MUTAT RES, V288, P133
[42]   DNA CONFORMATION MEDIATES AFLATOXIN B1-DNA BINDING AND THE FORMATION OF GUANINE N7 ADDUCTS BY AFLATOXIN-B1 8,9-EXO-EPOXIDE [J].
RANEY, VM ;
HARRIS, TM ;
STONE, MP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (01) :64-68
[43]   INTRALABORATORY OPTIMIZATION AND STANDARDIZATION OF MUTANT SCREENING CONDITIONS USED FOR A LAMBDA/LACI TRANSGENIC MOUSE MUTAGENESIS ASSAY .1. [J].
ROGERS, BJ ;
PROVOST, GS ;
YOUNG, RR ;
PUTMAN, DL ;
SHORT, JM .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 327 (1-2) :57-66
[44]   URINARY AFLATOXIN BIOMARKERS AND RISK OF HEPATOCELLULAR-CARCINOMA [J].
ROSS, RK ;
YUAN, JM ;
YU, MC ;
WOGAN, GN ;
QIAN, GS ;
TU, JT ;
GROOPMAN, JD ;
GAO, YT ;
HENDERSON, BE .
LANCET, 1992, 339 (8799) :943-946
[45]   INSERTION OF NUCLEOTIDES OPPOSITE APURINIC APYRIMIDINIC SITES IN DEOXYRIBONUCLEIC-ACID DURING INVITRO SYNTHESIS - UNIQUENESS OF ADENINE-NUCLEOTIDES [J].
SAGHER, D ;
STRAUSS, B .
BIOCHEMISTRY, 1983, 22 (19) :4518-4526
[46]   MUTAGENESIS BY AFLATOXIN IN M13 DNA - BASE-SUBSTITUTION MECHANISMS AND THE ORIGIN OF STRAND BIAS [J].
SAHASRABUDHE, S ;
SAMBAMURTI, K ;
HUMAYUN, MZ .
MOLECULAR & GENERAL GENETICS, 1989, 217 (01) :20-25
[47]  
SAMBAMURTI K, 1988, GENETICS, V120, P863
[48]   BIOLOGICAL PROPERTIES OF IMIDAZOLE RING-OPENED N7-METHYLGUANINE IN M13MP18-PHAGE DNA [J].
TUDEK, B ;
BOITEUX, S ;
LAVAL, J .
NUCLEIC ACIDS RESEARCH, 1992, 20 (12) :3079-3084
[49]  
VANNESS KP, 1994, CANCER RES, V54, P4573
[50]  
WOGAN GN, 1992, PROG CLIN BIOL RES, V374, P123